Dr. Eduardo Sanchez serves as Chief Medical Officer (CMO) for Prevention for the American Heart Association (AHA). He is the Principal Investigator (PI) of the National Hypertension Control Initiative (NHCI), a cooperative agreement with the U.S. Department of Health and Human Services (HHS) Office of Minority Health (OMH) and the Health Resources and Services Administration (HRSA). He is the AHA clinical lead on Target: BP (a joint blood pressure control initiative with the American Medical Association) and KnowDiabetesbyHeart (a joint cardiovascular risk factor control initiaitive with the American Diabetes Association). He is one of the AHA Presidential Advisory on Structural Racism and its health effects. Prior to joining AHA, he served as VP and CMO for BCBS of Texas (BCBSTX) where he focused on clinical prevention, and chronic disease management. He currently serves on the Board of Directors of Trust for America’s Health.

Dr. Sanchez obtained his MD from the University of Texas Southwestern Medical School in Dallas, an MPH from the UT Health Science Center at Houston School of Public Health and an MS in biomedical engineering from Duke University. He holds a BS in biomedical engineering and a BA in chemistry from Boston University. He is residency-trained in family medicine and a Fellow of the American Academy of Family Physicians (AAFP) and the American Heart Association (FAHA).